Waterloo Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,592
Closed -$278K 462
2025
Q2
$278K Sell
2,592
-886
-25% -$89.6K 0.02% 370
2025
Q1
$351K Buy
3,478
+553
+19% +$55.7K 0.03% 296
2024
Q4
$261K Buy
2,925
+21
+0.7% +$1.85K 0.03% 313
2024
Q3
$243K Buy
+2,904
New +$229K 0.03% 320
2023
Q2
Sell
-6,128
Closed -$307K 211
2023
Q1
$307K Buy
+6,128
New +$289K 0.09% 130

Other funds holding BSX

Waterloo Capital's BSX Position: Q3 2025 in Review

Waterloo Capital sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 2,592 shares — an estimated $278K sold.

Waterloo Capital first reported a position in BSX in Q1 2023 and held it in 5 quarters. The position peaked at $351K in Q1 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Waterloo Capital reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Waterloo Capital sold 2,592 Boston Scientific shares in Q3 2025, an estimated $278K.
  • Waterloo Capital first reported a position in Boston Scientific in Q1 2023 and held it in 5 quarters.
  • Waterloo Capital's Boston Scientific position peaked at $351K in Q1 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Waterloo Capital's 13F filing for Q3 2025, filed 5 Nov 2025.